Acura Pharmaceuticals (ACUR) Financial Statements

Acura Pharmaceuticals's market cap is currently $33.00K. The company's EPS TTM is $; its P/E ratio is ―; Acura Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.